Any place for depot triamcinolone in hay fever?
- 1 March 1999
- journal article
- review article
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 37 (3) , 17-18
- https://doi.org/10.1136/dtb.1999.37317
Abstract
The prevalence of hay fever (seasonal allergic rhinitis) in the UK has been increasing; for instance, it doubled from 10 to 20 per 1000 people between the 1970s and 1980s.1 For a few patients with severe hay fever symptoms, it sometimes helps to give a systemic corticosteroid; one possible option is the injection of a long-acting corticosteroid, such as triamcinolone. We have previously concluded that systemic corticosteroids have only a limited role, that is, when complete control of severe symptoms is judged essential (e.g. for a wedding or exam).2 Here we reconsider the case for depot triamcinolone injections in the management of hay fever.Keywords
This publication has 7 references indexed in Scilit:
- Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trialsBMJ, 1998
- Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?Clinical and Experimental Allergy, 1998
- Prevalence of asthma and hay fever in England and Wales.BMJ, 1987
- Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma.Thorax, 1984
- Pituitary adrenal recovery following short-term suppression with corticosteroidsThe American Journal of Medicine, 1979
- Soluble Injectable Steroids in AllergySouthern Medical Journal, 1971
- Clinical pharmacology of the anti‐inflammatory steroidsClinical Pharmacology & Therapeutics, 1961